Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptions.
Clarke, Noel W
van der Meulen, J
AffiliationDepartment of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, England
MetadataShow full item record
AbstractBACKGROUND: Cancer stage can be missing in national cancer registry records. We explored whether missing prostate cancer stage can be imputed using specific clinical assumptions. METHODS: Prostate cancer patients diagnosed between 2010 and 2013 were identified in English cancer registry data and linked to administrative hospital and mortality data (n?=?139,807). Missing staging items were imputed based on specific assumptions: men with recorded N-stage but missing M-stage have no distant metastases (M0); low/intermediate-risk men with missing N- and/or M-stage have no nodal disease (N0) or metastases; and high-risk men with missing M-stage have no metastases. We tested these clinical assumptions by comparing 4-year survival in men with the same recorded and imputed cancer stage. Multi-variable Cox regression was used to test the validity of the clinical assumptions and multiple imputation. RESULTS: Survival was similar for men with recorded N-stage but missing M-stage and corresponding men with M0 (89.5% vs 89.6%); for low/intermediate-risk men with missing M-stage and corresponding men with M0 (92.0% vs 93.1%); and for low/intermediate-risk men with missing N-stage and corresponding men with N0 (90.9% vs 93.7%). However, survival was different for high-risk men with missing M-stage and corresponding men with M0. Imputation based on clinical imputation performs as well as statistical multiple imputation. CONCLUSION: Specific clinical assumptions can be used to impute missing information on nodal involvement and distant metastases in some patients with prostate cancer.
CitationParry MG, Sujenthiran A, Cowling TE, Charman S, Nossiter J, Aggarwal A, et al. Imputation of missing prostate cancer stage in English cancer registry data based on clinical assumptions. Cancer Epidemiol. 2018 Nov 18;58:44-51.
- An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment.
- Authors: Cook MB, Hurwitz LM, Geczik AM, Butler EN
- Issue date: 2021 Jan
- Validity of using multiple imputation for "unknown" stage at diagnosis in population-based cancer registry data.
- Authors: Luo Q, Egger S, Yu XQ, Smith DP, O'Connell DL
- Issue date: 2017
- Bias due to missing SEER data in D'Amico risk stratification of prostate cancer.
- Authors: Elliott SP, Johnson DP, Jarosek SL, Konety BR, Adejoro OO, Virnig BA
- Issue date: 2012 Jun
- The Risk of Distant Metastases and Cancer Specific Survival in Men with Serum Prostate Specific Antigen Values above 100 ng/ml.
- Authors: Stattin K, Sandin F, Bratt O, Lambe M
- Issue date: 2015 Dec
- Collection of population-based cancer staging information in Western Australia--a feasibility study.
- Authors: Threlfall T, Wittorff J, Boutdara P, Heyworth J, Katris P, Sheiner H, Fritschi L
- Issue date: 2005 Aug 17